3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
2
Sarcoma
1
Myeloid
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
25
Peritoneal Neoplasms
17
Fallopian Tube Neoplasms
11
Carcinoma, Ovarian Epithelial
6
Stomach Neoplasms
5
Colorectal Neoplasms
4
Colonic Neoplasms
3
Adrenocortical Carcinoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Neoplasms
2
Mesothelioma
2
Hyperthermia
2
Gastrointestinal Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Postoperative Complications
1
Pelvic Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Low Anterior Resection Syndrome
1
Liposarcoma
1
High Grade Serous Ovarian
1
Brenner Tumor
1
Interventions
pembrolizumab
2
fludarabine
2
SS1(dsFv)PE38
2
Platinum
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cyclophosphamide
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
enzalutamide
1
entinostat
1
X-Rays
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Polymerase Chain Reaction
1
Paclitaxel
1
Nivolumab
1
Microarray Analysis
1
Megestrol Acetate
1
Magnetic Resonance Spectroscopy
1
Levoleucovorin
1
Leucovorin
1
Ipilimumab
1
Interleukin-2
1
In Situ Hybridization, Fluorescence
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Cytoreduction Surgical Procedures
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled